Bioequivalence study of oseltamivir phosphate capsules

• At: 2007 FIP Congress in Beijing (China)
• Type: Poster
• By: CHEN, Xiaoyan (Institute of Materia Medica, Shanghai, China)
• Co-author(s): Dai, Xiaojian (Institute of Materia Medica, SHANGHAI, China)
  Zhong, Dafang (Institute of Materia Medica, SHANGHAI, China)
  Chen, Wangsheng (Shanghai Changzheng Hospital, SHANGHAI, China)
  
• Abstract:

  OBJECTIVE A study was conducted to establish the bioequivalence between a newly developed Oseltamivir Phosphate Capsules (as the test formulation, Shanghai Sunve Pharmaceutical Co., Ltd, China) and TamifluÂ[RSYMBOL] (as the reference formulation, Roche, Switzerland). METHODS The clinical investigation was designed as a randomized, open-labelled ..

The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login